Options Brief: BioSante Pharmaceuticals

Shares of BioSante Pharmaceuticals BPAX are lower on the session by 1.86%, trading at $3.64. Overall put volume is now running at 5.99x the daily average, with 60% of all puts traded being purchases on the offer. 2,611 contracts have traded on the session so far. BioSante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: OptionsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!